Previous Article | Next Article ![]()
Infection and Immunity, January 1999, p. 319-326, Vol. 67, No. 1
Department of Microbiology and Immunology,
Emory University School of Medicine, Atlanta, Georgia 30322
Received 15 June 1998/Returned for modification 5 October
1998/Accepted 16 October 1998
The lipopolysaccharide (LPS) structure of Salmonella
typhimurium has been correlated with the virulence of wild-type
strain LT2. Mutants of LT2 with truncated polysaccharide portions of LPS are less virulent than strains with a complete LPS structure. Polyclonal T cells and monoclonal T-cell hybridomas were more reactive
to heat-killed rough mutants than to heat-killed smooth strains, as
measured by interleukin-2 (IL-2) production. Using a large panel of
strains with truncated LPS molecules, we found that T-cell reactivity
decreased with certain lengths of polysaccharide. The decreased
response was not due to differential phagocytic uptake, IL-12
production, or major histocompatibility complex class II surface
expression by macrophages. Also, LT2 did not mediate any global
suppression since addition of LT2 did not diminish the response of T
cells specific for antigens unrelated to Salmonella. In an
experiment in which processing times were varied, we found that
antigens from rough strains were processed and presented more quickly
than those associated with smooth strains. At longer processing times,
epitopes from LT2 were presented well. We hypothesize that the slower
antigen processing and presentation of wild-type Salmonella
may be caused by masking of surface antigens by the longer
polysaccharide portion of smooth LPS. This blocking of effective
antigen presentation may contribute to the virulence of
Salmonella.
Typhoid fever, caused by
Salmonella typhi, is still a major health problem in
developing nations. Worldwide, sixteen million cases of typhoid fever
with 600,000 deaths are estimated annually (26).
Salmonella typhimurium, a murine pathogen, serves as a model
for typhoid fever. S. typhimurium, follows a course of
infection in mice similar to that of S. typhi in humans
(10, 50). The outcomes by several routes of infection in
mice (intraperitoneal [i.p.], intravenous [i.v.] and oral) are
similar (23, 50). It is important to understand the immune
response to S. typhimurium not only as a model for human
disease but also because of its extensive use in experimental vaccine
schemes as a carrier for epitopes from other pathogens (6, 63,
64).
One of the main virulence factors of Salmonella is its
lipopolysaccharide (LPS), a component of the outer membrane of
gram-negative bacteria (54). The LPS structure consists of
three regions: O-specific polysaccharide, core polysaccharide, and
lipid A. The O side chain gives the bacterium added virulence.
Truncations in the polysaccharide portion of LPS cause a reduction in
virulence. Based on colony morphology, mutant strains that have
incomplete LPS molecules are termed rough while the wild type is termed
smooth. Wild-type strains of S. typhimurium have a 50%
lethal dose of <10 organisms in susceptible mice (11),
while rough mutants are avirulent (50% lethal dose of
The basis for differential virulence of rough and smooth strains is not
known. A significant reason is the difference in serum sensitivities
between rough and smooth strains (52). Several other
comparisons have been made. Rough forms of Salmonella, in some studies, were found to be more potent cytokine inducers than smooth forms (13, 14, 53). Other studies have indicated that
virulence may be due to the superior ability of smooth strains to bind
and colonize HeLa cells in vitro (44) or murine epithelial cells in vivo (36). Upon oral challenge, smooth strains
outcompeted rough strains during infection of the gut (36).
Both rough and smooth strains could block phagosome-lysosome fusion to
enhance intracellular survival (5, 25). However, during
intracellular infection, rough strains were ultimately more susceptible
to killing (41, 51). When used in vaccination studies,
smooth and rough strains can both induce protective cell-mediated
immunity (45). Currently, it is unclear how these
observations relate to the mechanism of virulence as controlled by the
LPS structure. Our studies address the influence of LPS on antigen
presentation and the development of T-cell-mediated immunity.
While Bacterial strains.
The Lipopolysaccharide Mutant Kit (Kit
1), containing strains of Salmonella typhimurium, was
obtained from the Salmonella Genetic Stock Centre (University of
Calgary, Calgary, Alberta, Canada). Strains LT2 and SL1004 were kindly
provided by John Spitznagel (Emory University School of Medicine,
Atlanta, Ga.). The strains of S. typhimurium used in this
study and their relevant traits are listed in Table
1.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Polysaccharide Portion of Lipopolysaccharide
Regulates Antigen-Specific T-Cell Activation via Effects on
Macrophage-Mediated Antigen Processing
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
109) (30). All strains have a lipid A region
and a minimum of two 2-keto-3-deoxyoctulosonic acid moieties
(53). It is the lipid A region that mediates most of the
biological effects of LPS, including the induction of cytokines
(interleukin-1 [IL-1], IL-6, IL-12, and tumor necrosis factor alpha
from mononuclear cells (13, 58).

T cells play a significant role in resistance to infection
(43), protective immunity primarily involves
CD4+ 
T cells and has been demonstrated by adoptive
transfer (22) and subset depletion studies (47).
Clearance of infection was impaired in T-cell-receptor-alpha-negative
(TCR-
/
) mice which lack 
T cells
(65). To analyze the relationship between bacterial
virulence, LPS structure, and antigen presentation, we studied the
ability of 
T-cell hybridomas to respond to both smooth and rough
strains of Salmonella. We report a decreased murine T-cell
response to antigens associated with strains expressing a wild-type LPS
compared to the T-cell response to the same antigens present in rough
mutants. The decreased response does not appear to be caused by
differences in uptake by phagocytic cells, IL-12 production, major
histocompatibility complex (MHC) class II expression, or a globally
suppressive event. While the mechanism underlying the differential
virulence of smooth and rough strains remains unknown, the generation
of epitopes for a T-cell response appears to play a role. T-cell
hybridomas reactive to rough strains are not reactive to smooth strains
except at significantly longer antigen processing times. Smooth
strains, because of their complete LPS structure, may be more resistant
to antigen-processing enzymes and may block or slow the processing or
availability of particular epitopes. This may impede the activation of
T cells and account, in part, for the virulence of
Salmonella.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and methods
Results
Discussion
References
TABLE 1.
LPS chemotype and partial genotype of S. typhimurium strains used in this study
Mice and injections. Female C3HeB/FeJ mice obtained from the Jackson Laboratory (Bar Harbor, Maine) were used at 8 to 12 weeks of age. Mice were housed in microisolator cages, with laboratory chow and water available ad libitum. Injections of live S. typhimurium SL1004 or SA1377 were done i.p. (108 bacteria/mouse). Previous studies have shown that the outcome is the same by several routes of infection in mice (i.p., i.v., and oral) (23, 50).
S. typhimurium preparation. Heat-killed S. typhimurium (HKST) strains were prepared by growing bacteria in 50 ml of brain heart infusion (BHI) broth. The cultures were placed on a shaker and incubated overnight at 37°C. Bacteria were then pelleted by centrifugation, washed twice in cold phosphate-buffered saline (PBS), diluted in cold PBS to a concentration of 109/ml, and heated for 90 min in an 80°C water bath. To confirm heat killing, bacteria were plated on individual BHI plates.
Isolation of PEC.
Eight days after injection with bacteria,
peritoneal exudate cells (PEC) were recovered by peritoneal lavage with
cold (4°C) Hanks balanced salt solution containing 0.06% bovine
serum albumin, 10 mM HEPES buffer, 50 U of penicillin per ml, 50 µg
of streptomycin per ml, and 10 U of heparin per ml. Cells were
centrifuged and resuspended in culture medium: RPMI 1640 supplemented
with 10% heat-inactivated fetal calf serum (FCS), 5 × 10
5 M 2-mercaptoethanol, 0.5 mM sodium pyruvate, 10 mM
HEPES buffer, 50 U of penicillin per ml, 50 µg of streptomycin per
ml, and 2 mM L-glutamine. The recovered population was
approximately 60% lymphocytes and 40% macrophages by morphology.
ConA-elicited macrophages. C3HeB/FeJ mice were injected i.p. with 100 µg of concanavalin A (ConA). After 3 to 5 days, the PEC were recovered as described above and added to 96-well tissue culture plates (105/well). Nonadherent cells were removed by washes with warm culture medium and aspiration. The remaining adherent population was >98% macrophages based on morphology.
Assay media.
For experiments using PEC as a source of
antigen-presenting cells (APC) and T cells (see Fig. 1 and 2), the
culture medium was RPMI 1640 supplemented with 10% FCS (heat
inactivated), 5 × 10
5 M 2-mercaptoethanol, 0.5 mM
sodium pyruvate, 10 mM HEPES buffer, 50 U of penicillin per ml, 50 µg
of streptomycin per ml, and 2 mM L-glutatmine. The
experiments for which the results are shown in Fig. 6 and Table 2 were
also conducted with this medium formulation. For experiments using
T-cell hybridomas (see Fig. 3, 4, 5, and 7) the culture medium was
Dulbecco's modification of Eagle's medium (DMEM) plus 50 U of
penicillin per ml, 50 µg of streptomycin per ml, 2 mM
L-glutamine, and 10% FCS (heat inactivated).
Antigen-specific T-cell hybridomas.
T-cell hybridomas were
produced with minor adaptations of previously published techniques
(56). Mice were injected with live S. typhimurium
SL1004 as described previously. Eleven days later, PEC were harvested
as described above. T-cell enrichment was accomplished by the removal
of cells adherent to tissue culture dishes and nylon wool. T cells were
resuspended in DMEM plus 50 U of penicillin per ml, 50 µg of
streptomycin per ml, 2 mM L-glutamine, and 10% FCS and
added to 24-well plates containing irradiated spleen cells from
syngeneic mice, with heat-killed SL1004 serving as the antigen
(107 organisms/ml). After 4 days, T cells were fused to
cell line BW1100 (66) by using polyethylene glycol according
to standard techniques (31). All hybridomas were subcloned
by limiting dilution to ensure monoclonality. The T-cell hybridoma used
in experiments presented here, 18-15.18, is I-Ek restricted
and expresses the 
T-cell receptor (unpublished observations).
18-15.18 responds in vitro to antigens from S. typhimurium
and is cross reactive with S. dublin, S. minnesota, and Escherichia coli. 18-15.18 does not
react either to purified preparations of S. typhimurium LPS,
smooth, Ra, Rb, Rc, or Rd (Sigma Chemical Co., St. Louis, Mo.) or to
gram-positive organisms (data not shown).
T-cell activation assay. For experiments using PEC as a source of T cells (see Fig. 1 and 2), the concentration of cells was 3 × 105/well in a 96-well format. Bacteria were added for a period of 24 h. Supernatants were removed and the response was determined by the IL-2 assay described above. In the experiments for which the results are shown in Fig. 3, 4, 5, and 7, hybridomas 18-15.18, 3A9 (I-Ak restricted, hen egg lysozyme specific) (2), 2B7114 (H-2Kd restricted, listeriolysin O [LLO] [peptide 91-99] specific) (21), and IB5 (I-Ek restricted, LLO [peptide 215-234] specific) (56) were used at a concentration of 105 cells/well with ConA-elicited macrophages as APC (105/well). Response to the antigen was determined by IL-2 production. This protocol was modified to monitor the kinetics of antigen processing (see Fig. 7). Various concentrations of HKST were incubated with ConA-elicited macrophages (105/well) for 2 to 48 h. The extracellular bacteria were removed by washing, and the macrophages were fixed with 0.05% glutaraldehyde at each time point. T-cell hybridomas were then added for 24 h, and the response was determined by the IL-2 assay as described below.
Measurement of IL-2. IL-2 was used as an indicator of T-cell responsiveness as described previously (42). Twenty-four-hour cell-free supernatants from the T-cell activation assay were added to a 96-well plate containing an IL-2-dependent cell line (HT-2, 104 cells/well). The mixture was incubated at 37°C for 24 h. Cells were then pulsed with [3H]thymidine (1 µCi/well) and incubated at 37°C for an additional 18 to 24 h. Cells were harvested onto a glass filter with a Micromate 196 cell harvester (Packard Instrument Co., Inc., Downers Grove, Ill.) and then counted in a Matrix 96 counter (Packard Instrument). The number of counts per minute are directly related to the amount of IL-2 produced based on the linear portion of a standard curve. All assays were performed in triplicate, and results were reported as the average number of counts per minute (± standard deviation) for the triplicate samples.
Measurement of bacterial uptake. Bacteria were labeled in a manner similar to previously published techniques (9). Bacteria were grown in BHI medium containing 20 µCi of [3H]thymidine for 24 h. The bacteria were pelleted by centrifugation, resuspended in cold PBS, and washed three times. The bacteria were killed by heating in an 80°C water bath for 1 h. The bacteria were plated before and after heat killing on BHI plates to determine the number and inactivation. After the heat-killing procedure, the number of bacteria was determined in a Petroff-Hausser counting chamber. The bacteria were added to ConA-elicited macrophages for various lengths of time. The macrophages were washed three times with warm RPMI to remove extracellular bacteria and then lysed with cold 0.05% Triton X-100. The lysate was dried onto a Spot Plate (Packard Instrument). The level of radioactivity was determined in a Matrix 96 direct beta counter (Packard Instrument). A standard curve was generated by adding several dilutions to the Spot Plate for each bacterial strain. The number of bacteria in each experimental sample was determined by comparing the counts per minute to the counts per minute/number of bacteria for the standard. Uptake of live S. typhimurium was determined by centrifuging, plating, and counting of the bacteria as described above. The bacteria were added to ConA-elicited macrophages for various lengths of time in antibiotic-free RPMI. At each interval, the macrophages were washed three times with RPMI containing gentamicin (50 µg/ml) to remove and kill any extracellular bacteria and then were lysed with 0.05% Triton X-100, and the lysates were diluted in PBS and plated on BHI plates. The plates were incubated overnight at 37°C.
IL-12 ELISA. Female C3HeB/FeJ mice were injected i.p. with 2.5 ml of thioglycolate. After 5 days, the peritoneal macrophages were isolated and cultured with 105 heat-killed Salmonella organisms per ml for 24 h. IL-12p40 was detected in the supernatant by sandwich enzyme-linked immunosorbent assay (ELISA) (58). C17.8.20 was used as the capture antibody and C15.6.7.6 served as the detection antibody. Both antibodies recognize epitopes on the p40 chain of murine IL-12 and were provided by G. Trinchieri (Wistar Institute, Philadelphia, Pa.). Extravidin alkaline phosphatase was used to bind to the biotinylated detection antibody and p-nitrophenylphosphate served as the substrate. Absorbance was read at 405 nm by using a Microplate Autoreader model EL 311SX (Bio-Tek Instruments, Inc., Winooski, Vt.). The relationship between absorbance and IL-12 concentration was linear between 25 and 5,000 pg/ml, with correlation coefficients consistently >0.990.
MHC class II ELISA. Female C3HeB/FeJ mice were injected i.p. with 100 µg of ConA. After 5 days, the peritoneal macrophages were isolated and cultured with 107 heat-killed Salmonella organisms per ml for 24 h. The macrophages were then fixed with 0.05% glutaraldehyde. Surface MHC class II molecules were detected by using a biotinylated anti-I-Ek antibody. Extravidin alkaline phosphatase was used to bind to the biotinylated detection antibody and p-nitrophenylphosphate served as the substrate. Absorbance was read at 405 nm with a Microplate Autoreader model EL 311SX (Bio-Tek Instruments). Background was measured by using biotinylated mouse immunoglobulin G (IgG).
| |
RESULTS |
|---|
|
|
|---|
Differential reactivity of T cells from Salmonella-immunized mice. An initial observation showed that T cells isolated from S. typhimurium SL1004-immunized mice were reactive in vitro to heat-killed SL1004 but not to the wild-type LT2 strain. This observation was intriguing since SL1004 differs from LT2 only in LPS structure. This finding suggested that the complete LPS structure was somehow interfering with antigen presentation and/or T-cell recognition.
To study the effects of LPS on T-cell responsiveness, a panel of mutants of LT2 with progressively decreasing lengths of LPS was assembled (Table 1). Most of these mutants are otherwise isogenic. For example, strains LT2 and SA1377 are isogenic, except for the LPS, and generate very different patterns of T-cell reactivity. Figure 1 is representative of the results for several experiments that illustrated the T-cell response to the truncated LPS mutants. In these experiments, peritoneal T cells and macrophages from SL1004-immunized mice reacted in vitro with the heat-killed bacteria. The T-cell response to the strains increased as their LPS lengths decreased in the following ways. A significant increase in response occurred in the LPS transition from smooth to Ra and from Ra to Rb. The T-cell response reached a plateau at this point but in numerous experiments reached a maximum response to the Rd mutant SL1004 as seen from the results presented in later figures. The differential response of the T cells could be seen over a range of bacterial concentrations (105/ml to 108/ml), with 107/ml chosen as a representative dose for future experiments (Fig. 2).
|
|
Response of Salmonella-specific hybridomas to live and killed bacteria. Salmonella-specific T-cell hybridomas were constructed and defined to explore the differential T-cell responses to rough and smooth bacteria in a monoclonal T-cell population. Figure 3 is representative of the data obtained from in vitro assays that tested the reactivity of T-cell hybridoma 18-15.18 to heat-killed Salmonella strains, with ConA-elicited macrophages as APC. At several antigen concentrations, the trend was the same: T cells reacted more strongly to the truncated LPS mutants than to the wild-type strain LT2 at all doses. Again, the T-cell response increased as the LPS length decreased. Increasing the antigen dose by at least 100-fold did not overcome the lack of T-cell activation by the smooth strains. These experiments with T-cell hybridomas indicated that the differential response was not due to variability in polyclonal T-cell populations found in the PEC population. A similar pattern of differential responsiveness was observed with 21 independent T-cell hybridomas including those generated from immunizations with S. typhimurium LT2, SL1004, and SA1377.
|
|
Salmonella LT2 does not globally suppress antigen processing or presentation in vitro. Several investigators have proposed that LT2 or wild-type LPS is suppressive (3, 40). Because of this possibility, we investigated the ability of LT2 to hinder the response of MHC class I- and class II-restricted T-cell hybridomas to antigens not associated with Salmonella. The addition of heat-killed LT2 or purified LPS to hybridoma 3A9 did not suppress its ability to respond to the protein antigen HEL (Fig. 5A). Hybridomas 2B7114 and IB5 recognize LLO peptides 91-99 and 215-234, respectively, from Listeria monocytogenes. LT2 did not globally suppress the response to either LLO peptide (Fig. 5B and C). To determine if the presence of LT2 diminished the T-cell response to SL1004, PEC populations from SL1004-immunized mice were restimulated in vitro with heat-killed SL1004 plus various concentrations of heat-killed LT2. Even at the highest doses of LT2, reactivity to SL1004 was still apparent (data not shown). Thus, LT2 did not influence the ability of several hybridomas to respond to epitopes offered as whole proteins or synthetic peptides nor did it impair the response of peritoneal T cells to bacterial antigens.
|
Differential T-cell response is not accounted for by bacterial uptake, macrophage IL-12 induction, MHC class II expression, or LPS responsiveness. To rule out the possibility that the differences in T-cell reactivities were due to differences in the amount of available antigen, two different methods were used to determine the level of uptake of the S. typhimurium strains by macrophages. In Fig. 6A, [3H]thymidine-labeled heat-killed bacteria were added to macrophages for various lengths of time. The macrophages were washed thoroughly and then lysed to obtain only the cell-associated bacteria. There were no differences in uptake among eight strains ranging from smooth to deep rough in LPS character. In Fig. 6B, macrophages were cultured with live bacteria for periods up to 4 h, rinsed with medium containing the antibiotic gentamicin, and then lysed with Triton X-100. The antibiotic kills extracellular bacteria that may be attached to the macrophage surface; therefore, the number of recovered bacteria is a measure of those that were ingested. It appears that the number of both rough and smooth bacteria decreased after 1 h and then increased equally over time. Minor differences in uptake were within the limits of experimental error and could not account for the greatly reduced response to LT2 (Fig. 2 and 3). Uptake does not appear to be the reason epitopes from smooth strains are not presented effectively to T cells.
|
|
With longer processing times, epitopes from smooth strains are presented to T cells. The kinetics of processing and presentation of HKST strains were evaluated. In this experiment (Fig. 7), ConA-elicited macrophages were pretreated with HKST for various times and then fixed with glutaraldehyde. The monoclonal T-cell hybridoma (18-15.18) was added after fixation and the IL-2 response was determined. In keeping with other studies of antigen processing (70), there was a rapid increase in effective presentation of SL1004 and SA1377 in 1 to 2 h. In contrast, during the first 12 h, the epitope from LT2 was not presented as effectively as the same epitope carried by SL1004 or SA1377. However, with longer processing times (>24 h), there was a vigorous response to LT2. These results indicated that the relevant epitope was present in LT2, but because of LPS-mediated interference, longer processing times were required.
|
| |
DISCUSSION |
|---|
|
|
|---|
These experiments provide insight into how S. typhimurium interacts with macrophages and T cells to generate an effective immune response. CD4+ T cells have been shown to be protective against Salmonella infection via adoptive transfer or depletion of T cell subsets (17, 47). While antibodies and, to a lesser extent, cytotoxic T lymphocytes can play a role in the immune response to Salmonella, protective immunity against oral or i.p. challenge can be primarily mediated by CD4+ T cells (22, 38, 65). Our studies have focused specifically on the activation of CD4+ T cells by Salmonella antigens. We have observed that this subset of T cells is less responsive to wild-type Salmonella strains than to avirulent strains in vitro (Fig. 1). Our results agree with those of previous studies which showed a diminished response to antigens associated with smooth strains of Salmonella (67). The major difference between the wild-type strains and the mutant strains used in this study is the presence of a full-length LPS. Because the T cells that we used did not respond directly to LPS and because CD4+ T cells generally recognize peptide epitopes (15), it seemed possible that LPS was influencing the generation of peptide epitopes at the level of the macrophage.
We observed an increase in the T-cell response to Salmonella strains with truncated LPS structures. This observation, though initially evaluated with polyclonal T-cell populations (Fig. 1), was also confirmed with a monoclonal T-cell population (Fig. 3) and later with 21 additional independent T-cell hybridomas (data not shown). The hybridoma illustrated here was reactive to an epitope associated with an outer membrane protein preparation in the context of I-Ek.
Our data indicated that LT2 did not adversely affect the presentation of antigens not associated with the LT2 organism. Previously, studies in our laboratory showed that live LT2 organisms did not diminish the response of T-cell hybridoma D011.10 to ovalbumin (8). This finding indicated that LT2 was not globally suppressing processing of other antigens. The addition of heat-killed LT2 bacteria or purified LPS also did not interfere with the processing and presentation of hen egg lysozyme to a specific hybridoma, 3A9 (Fig. 5). Wild-type Salmonella also does not suppress the responses of Listeria-specific hybridomas to their peptide ligand. The hybridomas IB5 and 2B7114 mixed with their peptide ligand and various amounts of LT2 displayed a normal response (Fig. 5B and C). LT2 also did not diminish the T-cell hybridoma response to antigens displayed by SL1004 when the two strains were mixed in vitro with APC and a Salmonella-specific hybridoma (data not shown). While others have noted suppressive mechanisms associated with Salmonella (4, 12, 20), these mechanisms appeared to operate for longer periods of time and by using proliferation and antibody formation as readouts of immune function. Some suppressive mechanisms may operate via cytokines and NO production by macrophages (24, 39). Our use of T-cell hybridomas with minimal activation requirements may represent a system that is not susceptible to the globally suppressive activities of Salmonella as others have noted.
In many instances, rough strains of bacteria have been shown to be
taken up preferentially by phagocytic cells (16, 35, 67).
Conversely, in other studies, smooth and rough strains have been shown
to have no significant differences in the rates of phagocytic uptake
(5, 25, 51, 68). We confirmed and extended these
observations with eight representative S. typhimurium strains (Fig. 6), using both live and killed bacteria. The effective association of bacteria with macrophages was monitored by uptake of
radiolabeled dead bacteria, by the uptake and survival of live bacteria, and also by the ability of bacteria to induce cytokine (IL-12) production (Table 2). In all cases, it is apparent that both
smooth and rough strains can associate equally with macrophages as
monitored by both physical and functional parameters. Both smooth and
rough strains bind LPS binding protein equally, which in turn binds to
the CD14 receptor on macrophages (61). The levels of uptake
mediated via CD14 should then be similar. While we and others
(67) have noted very small differences in uptake levels of
rough and smooth strains, it is clear that the small changes in uptake
cannot account for the
100-fold differences in antigen presentation
when smooth and rough strains are compared.
Our studies indicate that Salmonella can alter antigen processing and presentation during the first 12 h of bacterium-macrophage interaction by using T-cell hybridoma activation as our readout. The activation of T-cell hybridomas can occur independently of cytokines and accessory molecules (29). This readout coupled with the use of fixed APC effectively isolates potential regulatory effects at the level of antigen processing and presentation. Allowing additional time for the macrophages to process the heat-killed strains revealed that antigens from LT2 could be presented to T-cell hybridomas (Fig. 7). Thus, rather than the absence of the relevant epitope in LT2, it is apparent that the presence of smooth LPS delays the generation of the epitope during antigen processing. These results are compatible with a physical blocking or masking of epitopes by the polysaccharide portion of LPS. In fact, polysaccharides have been shown to interfere with MHC class II-restricted antigen presentation (18, 34).
It is possible that protein epitopes are protected from proteolysis in
the endosome by LPS. Outer membrane proteins have been shown to be
closely associated with LPS and may be tightly bound to LPS (1,
19, 32, 60). The phenomenon of LPS masking of outer membrane
proteins has been observed for Neisseria gonorrheae in which
LPS inhibits binding of cathepsin B to three outer membrane proteins
(57). LPS also has been shown to block the binding of
bacteriophages and colicins to their outer membrane protein receptors
in smooth strains of E. coli (62). S. typhimurium strains with complete LPS structures are insensitive
to phage attack, possibly due to steric hindrance by the O side chain
(49). Smooth strains are resistant to lysis by the
complement pathway membrane attack complex because the complex is
prevented by LPS from assembling at the membrane surface (27,
28). It is conceivable that the LPS could disrupt or interfere
with processing and presentation of LT2 antigens, especially antigens
present in the outer membrane. If the polysaccharide portion of LPS
interferes with the processing and availability of certain epitopes, it
would follow that the repertoires of T cells generated by smooth and
rough strains would be different. In this regard, our preliminary
studies do indicate differences in the specificities of such T cells.
While the vast majority of T-cell hybridomas generated from mice
immunized with rough strains behave as the representative one described
here (Fig. 3, rough strains
smooth strains), we have noted that
T-cell hybridomas which recognize epitopes that do not appear to be
controlled by the complete polysaccharide portion of LPS exist. Some of
these hybridomas, generated from mice immunized with smooth strains, react equally well with both smooth and rough strains. These results indicate that the specificity of the TCR influences the relative response to smooth and rough strains and further indicates that the
level of control mediated by LPS is at the level of epitope generation
or availability. These results not only have implications for the
mechanism of virulence by Salmonella but also relate to the
use of Salmonella as a vaccine strain or carrier of
passenger epitopes.
In this study, we have attempted to understand the mechanisms by which LT2 is more virulent than strains with truncated LPS by focusing on the initial events in the bacterium-macrophage interaction. Our studies indicate that inefficient antigen processing and presentation are linked to virulence. Thus, we suggest that part of the complex phenomenon of virulence is mediated by altered antigen processing and differential T-cell recognition.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported in part by National Institute of Allergy and Infectious Diseases grants RO1 AI-35285 and AI-34065.
The advice and technical assistance provided by Marianne Skeen and Mark Miller are greatly appreciated.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Room 3170, Emory University School of Medicine, 1510 Clifton Rd., Atlanta, GA 30322. Phone: (404) 727-0294. Fax: (404) 727-3659. E-mail: nzirk{at}bimcore.emory.edu.
Editor: J. R. McGhee
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alberti, S., F. Rodriquez-Quinones, T. Schirmer, G. Rummel, J. M. Tomas, J. P. Rosenbusch, and V. J. Benedi. 1995. A porin from Klebsiella pneumoniae: sequence homology, three-dimensional model, and complement binding. Infect. Immun. 63:903-910[Abstract]. |
| 2. | Allen, P. M., and E. R. Unanue. 1984. Processing and presentation of hen egg-white lysozyme by macrophages. Immunobiology 168:182-188[Medline]. |
| 3. | Al-Ramadi, B. K., M. A. Brodkin, D. M. Mosser, and T. K. Eisenstein. 1991. Immunosuppression induced by attenuated Salmonella. Evidence for mediation by macrophage precursors. J. Immunol. 146:2737-2746[Abstract]. |
| 4. | Arai, T., and K. Matsui. 1997. A purified protein from Salmonella typhimurium inhibits high-affinity interleukin-2 receptor expression on CTLL-2 cells. FEMS Immunol. Med. Microbiol. 17:155-160[Medline]. |
| 5. |
Buchmeier, N. A., and F. Heffron.
1991.
Inhibition of macrophage phagosome-lysosome fusion by Salmonella typhimurium.
Infect. Immun.
59:2232-2238 |
| 6. | Chatfield, S. N., G. Dougan, and M. Roberts. 1994. Progress in the development of multivalent oral vaccines based on live attenuated Salmonella, p. 55-86. In E. Kurstak (ed.), Modern vaccinology. Plenum Medical, New York, N.Y. |
| 7. | Chatterjee, A. K., K. E. Sanderson, and H. Ross. 1976. Influence of temperature on growth of lipopolysaccharide-deficient (rough) mutants of Salmonella typhimurium and Salmonella minnesota. Can. J. Microbiol. 22:1540-1548[Medline]. |
| 8. |
Cluff, C. W.,
M. Garcia, and H. K. Ziegler.
1990.
Intracellular hemolysin-producing Listeria monocytogenes strains inhibit macrophage-mediated antigen processing.
Infect. Immun.
58:3601-3612 |
| 9. | Davies, W. A. 1982. Kinetics of killing Listeria monocytogenes by macrophages: correlation of 3H-DNA release from labeled bacteria and changes in numbers of viable organisms by mathematical model. J. Reticuloendothel. Soc. 32:461-476[Medline]. |
| 10. | Dunlap, N. E., W. Benjamin, Jr., and D. E. Briles. 1994. The intracellular nature of Salmonella infection during the early stages of mouse typhoid. Immunol. Ser. 60:303-312[Medline]. |
| 11. | Eisenstein, T. K., L. M. Killar, and B. M. Sultzer. 1984. Immunity to infection with Salmonella typhimurium: mouse-strain differences in vaccine- and serum-mediated protection. J. Infect. Dis. 150:425-435[Medline]. |
| 12. | Eisenstein, T. K., J. J. Meissler, Jr., S. I. Miller, and B. A. Stocker. 1998. Immunosuppression and nitric oxide production induced by parenteral live Salmonella vaccines do not correlate with protective capacity: a phoP::Tn10 mutant does not suppress but does protect. Vaccine 16:24-32[Medline]. |
| 13. | Flad, H. D., L. H., E. T. Rietschel, and A. J. Ulmer. 1993. Agonists and antagonists for lipopolysaccharide-induced cytokines. Immunobiology 187:303-316[Medline]. |
| 14. | Flebbe, L., S. W. Vukajlovich, and D. C. Morrison. 1989. Immunostimulation of C3H/HeJ lymphoid cells by R-chemotype lipopolysaccharide preparations. J. Immunol. 142:642-652[Abstract]. |
| 15. | Fremont, D. H., W. A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001-1004[Abstract]. |
| 16. |
Friedberg, D., and M. Shilo.
1970.
Role of cell wall structure of Salmonella in the interaction with phagocytes.
Infect. Immun.
2:279-285 |
| 17. |
Gautreaux, M. D.,
E. A. Deitch, and R. D. Berg.
1994.
T lymphocytes in host defense against bacterial translocation from the gastrointestinal tract.
Infect. Immun.
62:2874-2884 |
| 18. | Gonzalez-Fernandez, M., E. Carrasco-Marin, C. Alvarez-Dominguez, I. M. Outschoorn, and F. Leyva-Cobian. 1997. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell. Cell. Immunol. 176:1-13[Medline]. |
| 19. | Hancock, R. E. W., D. N. Karunaratne, and C. Bernegger-Egli. 1994. Molecular organization and structural role of outer membrane macromolecules, p. 263-279. In J. M. Ghuysen, and R. Hakenbeck (ed.), Bacterial cell wall. Elsevier Science Publishers, New York, N.Y. |
| 20. |
Hassan, J. O., and R. Curtiss, III.
1994.
Virulent Salmonella typhimurium-induced lymphocyte depletion and immunosuppression in chickens.
Infect. Immun.
62:2027-2036 |
| 21. | Hiltbold, E. M., S. A. Safley, and H. K. Ziegler. 1996. The presentation of class I and class II epitopes of listeriolysin O is regulated by intracellular localization and by intercellular spread of Listeria monocytogenes. J. Immunol. 157:1163-1175[Abstract]. |
| 22. | Hougen, H. P., and E. T. Jensen. 1990. Experimental Salmonella typhimurium infections in rats. III. Transfer of immunity with primed lymphocyte subpopulations. APMIS 98:1015-1021[Medline]. |
| 23. |
Hsu, H. S.
1989.
Pathogenesis and immunity in murine salmonellosis.
Microbiol. Rev.
53:390-409 |
| 24. | Huang, D., M. G. Schwacha, and T. K. Eisenstein. 1996. Attenuated Salmonella vaccine-induced suppression of murine spleen cell responses to mitogen is mediated by macrophage nitric oxide: quantitative aspects. Infect. Immun. 64:3786-3792[Abstract]. |
| 25. | Ishibashi, Y., and T. Arai. 1990. Specific inhibition of phagosome-lysosome fusion in murine macrophages mediated by Salmonella typhimurium infection. FEMS Microbiol. Immunol. 2:35-43[Medline]. |
| 26. | Ivanoff, B., M. M. Levine, and P. H. Lambert. 1994. Vaccination against typhoid fever: present status. Bull. W. H. O. 72:957-971[Medline]. |
| 27. |
Joiner, K. A.,
C. H. Hammer,
E. J. Brown,
R. J. Cole, and M. M. Frank.
1982.
Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
J. Exp. Med.
155:797-808 |
| 28. |
Joiner, K. A.,
C. H. Hammer,
E. J. Brown, and M. M. Frank.
1982.
Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
J. Exp. Med.
155:809-819 |
| 29. |
Kappler, J. W.,
B. Skidmore,
J. White, and P. Marrack.
1981.
Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.
J. Exp. Med.
153:1198-1214 |
| 30. | Kita, E., F. Nishikawa, N. Kamikaidou, D. Oku, K. Yasui, and S. Kashiba. 1992. Mechanism of the protective immunity against murine typhoid: persistence of Salmonella L forms in the liver after immunization with live-cell vaccines. FEMS Microbiol. Immunol. 5:191-199[Medline]. |
| 31. | Kruisbeek, A. M. 1991. Production of mouse T cell hybridomas, p. 3.14.1. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology. Wiley-Interscience, New York, N.Y. |
| 32. |
Kuusi, N.,
N. M.,
H. Saxen, and P. H. Makela.
1981.
Immunization with major outer membrane protein (porin) preparations in experimental murine salmonellosis: effect of lipopolysaccharide.
Infect. Immun.
34:328-332 |
| 33. | Lehmann, V., G. Hammerling, M. Nurminen, I. Minner, E. Ruschmann, O. Luderitz, T. T. Kuo, and B. A. Stocker. 1973. A new class of heptose-defective mutant of Salmonella typhimurium. Eur. J. Biochem. 32:268-275[Medline]. |
| 34. | Leyva-Cobian, F., and E. R. Unanue. 1988. Intracellular interference with antigen presentation. J. Immunol. 141:1445-1450[Abstract]. |
| 35. | Liang-Takasaki, C. J., P. H. Makela, and L. Leive. 1982. Phagocytosis of bacteria by macrophages: changing the carbohydrate of lipopolysaccharide alters interaction with complement and macrophages. J. Immunol. 128:1229-1235[Abstract]. |
| 36. | Licht, T. R., K. A. Krogfelt, P. S. Cohen, L. K. Poulsen, J. Urbance, and S. Molin. 1996. Role of lipopolysaccharide in colonization of the mouse intestine by Salmonella typhimurium studied by in situ hybridization. Infect. Immun. 64:3811-3817[Abstract]. |
| 37. |
MacLachlan, P. R., and K. E. Sanderson.
1985.
Transformation of Salmonella typhimurium with plasmid DNA: differences between rough and smooth strains.
J. Bacteriol.
161:442-445 |
| 38. |
Mastroeni, P.,
R. B. Villarreal, and C. E. Hormaeche.
1993.
Adoptive transfer of immunity to oral challenge with virulent Salmonellae in innately susceptible BALB/c mice requires both immune serum and T cells.
Infect. Immun.
61:3981-3984 |
| 39. | Matsui, K. 1996. A purified protein from Salmonella typhimurium inhibits proliferation of murine splenic anti-CD3 antibody-activated T-lymphocytes. FEMS Immunol. Med. Microbiol. 14:121-127[Medline]. |
| 40. | Matsui, K., and T. Arai. 1993. Immunosuppression induced by Salmonella involves inhibition of tyrosine phosphorylation in murine T lymphocytes. FEMS Immunol. Med. Microbiol. 7:345-354[Medline]. |
| 41. | Mattsby-Baltzer, I., B. Ahlstrom, L. Edebo, and P. de Man. 1996. Susceptibility of lipopolysaccharide-responsive and -hyporesponsive ItyS Mice to infection with rough mutants of Salmonella typhimurium. Infect. Immun. 64:1321-1327[Abstract]. |
| 42. | Miller, M. A., M. J. Skeen, and H. K. Ziegler. 1995. Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes. J. Immunol. 155:4817-4828[Abstract]. |
| 43. |
Mixter, P. F.,
V. Camerini,
B. J. Stone,
V. L. Miller, and M. Kronenberg.
1994.
Mouse T lymphocytes that express a ![]() T-cell antigen receptor contribute to resistance to Salmonella infection in vivo.
Infect. Immun.
62:4618-4621 |
| 44. | Mroczenski-Wildey, M. J., J. L. Di Fabio, and F. C. Cabello. 1989. Invasion and lysis of HeLa cell monolayers by Salmonella typhi: the role of lipopolysaccharide. Microb. Pathog. 6:143-152[Medline]. |
| 45. | Muotiala, A., M. Hovi, and P. H. Makela. 1989. Protective immunity in mouse salmonellosis: comparison of smooth and rough live and killed vaccines. Microb. Pathog. 6:51-60[Medline]. |
| 46. | Nakano, M., and K. Saito. 1969. Chemical components in the cell wall of Salmonella typhimurium affecting its virulence and immunogenicity in mice. Nature 222:1085-1086[Medline]. |
| 47. | Nauciel, C. 1990. Role of CD4+ T cells and T-independent mechanisms in acquired resistance to Salmonella typhimurium infection. J. Immunol. 145:1265-1269[Abstract]. |
| 48. |
Nikaido, H.,
M. Levinthal,
K. Nikaido, and K. Nakane.
1967.
Extended deletions in the histidine-rough-B region of the Salmonella chromosome.
Proc. Natl. Acad. Sci. USA
57:1825-1832 |
| 49. |
Nurminen, M.,
K. Lounatmaa,
M. Sarvas,
P. H. Makela, and T. Nakae.
1976.
Bacteriophage-resistant mutants of Salmonella typhimurium deficient in two major outer membrane proteins.
J. Bacteriol.
127:941-955 |
| 50. | O'Brien, A. D. 1986. Influence of host genes on resistance of inbred mice to lethal infection with Salmonella typhimurium. Curr. Top. Microbiol. Immunol. 124:37-48[Medline]. |
| 51. |
Okamura, N., and J. K. Spitznagel.
1982.
Outer membrane mutants of Salmonella typhimurium LT2 have lipopolysaccharide-dependent resistance to the bactericidal activity of anaerobic human neutrophils.
Infect. Immun.
36:1086-1095 |
| 52. | Ornellas, E. P., R. J. Roantree, and J. P. Steward. 1970. The specificity and importance of humoral antibody in the protection of mice against intraperitoneal challenge with complement-sensitive and complement-resistant Salmonella. J. Infect. Dis. 121:113-123[Medline]. |
| 53. |
Raetz, C. R.
1993.
Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction.
J. Bacteriol.
175:5745-5753 |
| 54. | Reeves, P. 1994. Biosynthesis and assembly of lipopolysaccharide, p. 281-317. In J. M. Ghuysen, and R. Hakenbeck (ed.), Bacterial cell wall. Elsevier Science Publishers, New York, N.Y. |
| 55. |
Roantree, R. J.,
T. T. Kuo, and D. G. MacPhee.
1977.
The effect of defined lipopolysaccharide core defects upon antibiotic resistances of Salmonella typhimurium.
J. Gen. Microbiol.
103:223-234 |
| 56. | Safley, S. A., P. E. Jensen, P. A. Reay, and H. K. Ziegler. 1995. Mechanisms of T cell epitope immunodominance analyzed in murine listeriosis. J. Immunol. 155:4355-4366[Abstract]. |
| 57. |
Shafer, W. M.
1988.
Lipopolysaccharide masking of gonococcal outer-membrane proteins modulates binding of bacterial cathepsin G to gonococci.
J. Gen. Microbiol.
134:539-545 |
| 58. | Skeen, M. J., M. A. Miller, T. M. Shinnick, and H. K. Ziegler. 1996. Regulation of murine macrophage IL-12 production. J. Immunol. 156:1196-1206[Abstract]. |
| 59. | Sultzer, B. M., R. Castagna, J. Bandekar, and P. Wong. 1993. Lipopolysaccharide nonresponder cells: the C3H/HeJ defect. Immunobiology 187:257-271[Medline]. |
| 60. |
Sultzer, B. M., and G. W. Goodman.
1976.
Endotoxin protein: a B-cell mitogen and polyclonal activator of C3H/HeJ lymphocytes.
J. Exp. Med.
144:821-827 |
| 61. | Ulevitch, R. J., and P. S. Tobias. 1995. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:437-457[Medline]. |
| 62. |
van der Ley, P.,
P. de Graaff, and J. Tommassen.
1986.
Shielding of Escherichia coli outer membrane proteins as receptors for bacteriophages and colicins by O-antigenic chains of lipopolysaccharide.
J. Bacteriol.
168:449-451 |
| 63. | Verma, N. K., H. K. Ziegler, B. A. Stocker, and G. K. Schoolnik. 1995. Induction of a cellular immune response to a defined T-cell epitope as an insert in the flagellin of a live vaccine strain of Salmonella. Vaccine 13:235-244[Medline]. |
| 64. | Verma, N. K., H. K. Ziegler, M. Wilson, M. Khan, S. Safley, B. A. Stocker, and G. K. Schoolnik. 1995. Delivery of class I and class II MHC-restricted T-cell epitopes of listeriolysin of Listeria monocytogenes by attenuated Salmonella. Vaccine 13:142-150[Medline]. |
| 65. |
Weintraub, B. C.,
L. Eckmann,
S. Okamoto,
M. Hense,
S. M. Hedrick, and J. Fierer.
1997.
Role of ![]() and ![]() T cells in the host response to Salmonella infection as demonstrated in T-cell-receptor-deficient mice of defined Ity genotypes.
Infect. Immun.
65:2306-2312[Abstract].
|
| 66. | White, J., M. Blackman, J. Bill, J. Kappler, P. Marrack, D. P. Gold, and W. Born. 1989. Two better cell lines for making hybridomas expressing specific T cell receptors. J. Immunol. 143:1822-1825[Abstract]. |
| 67. |
Wick, M. J.,
C. V. Harding,
S. J. Normark, and J. D. Pfeifer.
1994.
Parameters that influence the efficiency of processing antigenic epitopes expressed in Salmonella typhimurium.
Infect. Immun.
62:4542-4548 |
| 68. | Wick, M. J., C. V. Harding, N. J. Twesten, S. J. Normark, and J. D. Pfeifer. 1995. The phoP locus influences processing and presentation of Salmonella typhimurium antigens by activated macrophages. Mol. Microbiol. 16:465-476[Medline]. |
| 69. | Yamamoto, N., and T. F. Anderson. 1961. Genomic masking and recombination between serologically unrelated phages P22 and P221. Virology 14:430-439[Medline]. |
| 70. |
Ziegler, H. K., and E. R. Unanue.
1982.
Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells.
Proc. Natl. Acad. Sci. USA
79:175-178 |
| 71. |
Zinder, N. D., and J. Lederberg.
1952.
Genetic exchange in Salmonella.
J. Bacteriol.
64:679-699 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»